Key points:
- Financial giants made a bearish move on Amgen, which means they think the stock price will go down.
- Analysts found some unusual trades in options history for Amgen, with more bears than bulls.
- Whales targeted a range of prices from $290 to $305 for Amgen over the last 3 months.
- Options volume and open interest show how much people are interested in buying or selling Amgen's options at different strike prices.

Summary:
Some big players in the financial market bet that Amgen, a company that makes medicines, will lose value soon. They used special contracts called options to express their opinion. Our analysis found more of these bearish contracts than bullish ones. We also looked at how much people want to trade Amgen's options and saw that whales were focusing on a price range between $290 and $305 for the company. This means they think this is where Amgen will be in the near future. Read from source...

- The title is misleading as it implies that there is some exclusive or secretive information being revealed behind the scenes of Amgen's options trends. In reality, the article only presents a superficial analysis of public data from options history and does not offer any original insights or value to investors or readers.
- The article uses vague terms such as "unusual trades" and "whales" without defining what constitutes them or providing any evidence or sources for these claims. This creates confusion and ambiguity for the audience, who might be interested in knowing more about the actual trading activities and motives of these entities.
- The article focuses too much on quantitative data such as volume, open interest, strike prices, and trade values, without explaining how they are relevant or meaningful for understanding Amgen's options trends. The article also does not provide any context or comparison to other similar companies or industries, which would help readers to assess the significance and implications of these data points.
- The article includes a brief overview of Amgen's business activities and products, but this information is outdated and incomplete, as it does not mention any of the company's recent launches or acquisitions that have occurred since 2023. This shows a lack of research and attention to detail on the part of the author(s), who seem more interested in generating clicks than delivering quality content.
- The article ends with an advertisement for the 2023 Horizon acquisition, which is irrelevant and confusing, as it has nothing to do with Amgen's options trends or the main topic of the article. This suggests that the author(s) are using the article as a platform to promote their own interests or agenda, rather than informing or educating the readers.

1. Sell short Amgen stock at a price above $305.0, with a target price of around $290.0. This is based on the analysis of volume and open interest, which indicates that whales have been targeting this price range for the past three months. The bearish sentiment among traders (53%) also supports this strategy. Risks: Amgen may announce positive news or results that could trigger a short squeeze, causing significant losses for short sellers. Therefore, it is important to monitor the company's developments closely and adjust the stop-loss accordingly. Additionally, there is always the possibility of unforeseen market events or external factors that may impact Amgen's stock price negatively.